The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma.
Ewing
Gideon P
GP
Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. gideon.ewing@vanderbilt.edu
Goff
Laura W
LW